Skip to main content

Trio of Vanderbilt scientists set for next Discovery Lecture

Dec. 6, 2018, 10:29 AM

 

by Roslin Thoppil

Three Vanderbilt scientists will discuss innovative new and ongoing programs during a Cutting-Edge Discovery Lecture on Thursday, Dec. 13. The lecture will begin at 4 p.m. in room 208 Light Hall.

Eric Skaar, PhD

Eric Skaar, PhD, Ernest W. Goodpasture Professor of Pathology, vice chair for Basic Research in the Department of Pathology, Microbiology, and Immunology, and director of the Division of Molecular Pathogenesis, will discuss “The Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4).” VI4, which Skaar directs, engages in research that bridges the disciplines of immunology and infection biology to improve human health.

Danny Winder, PhD, Bixler-Johnson-Mayes Professor of Basic Sciences and professor of Molecular Physiology and Biophysics, Pharmacology and Psychiatry, will discuss new and ongoing programs at the Vanderbilt Center for Addiction Research (VCAR), which he directs. VCAR seeks to understand detailed molecular events within the brain that drive addictive behaviors and develop treatment strategies to curb addiction.

Danny Winder, PhD

Katherine Hartmann, MD, PhD, Lucius E. Burch Professor of Reproductive Physiology and Family Planning and associate dean for Clinical and Translational Scientist Development, will discuss “Resources to Ensure Early Career Scientists Thrive.”

One resource Hartmann established is the Doris Duke Partners program, which helps eligible faculty keep their work on track with support from the Doris Duke Charitable Foundation and Vanderbilt.

The talks, part of the Flexner Discovery Lecture Series, are sponsored by the Offices of the Executive Vice President for Research at Vanderbilt University Medical Center and the Dean of Basic Sciences at Vanderbilt University School of Medicine.

Katherine Hartmann, MD, PhD

For a complete schedule of the Flexner Discovery Lecture series and archived video of previous lectures, go to www.mc.vanderbilt.edu/discoveryseries.

Recent Stories from VUMC News and Communications Publications

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

Momentum

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

more